Company Filing History:
Years Active: 2007
Title: The Innovative Contributions of Bodo Jaeger
Introduction
Bodo Jaeger is a notable inventor based in Hannover, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of diseases that require the inhibition or reduction of pH value-regulating bicarbonate transporter proteins. His work has implications for various clinical conditions affecting larger mammals and humans.
Latest Patents
Jaeger holds a patent for a method aimed at treating diseases that necessitate the inhibition of bicarbonate transporter proteins. This patent details the use of selective imidazoline receptor agonists, including moxonidine, rilmenidine, LNP-509, S-23515, PMS-812, PMS-847, and BU-98008. These compounds are utilized in pharmaceutical preparations to address conditions such as osteoporosis, gastric ulcers, and neuropsychiatric diseases like depression and Alzheimer's disease.
Career Highlights
Bodo Jaeger is associated with Solvay Pharmaceuticals GmbH, where he has been instrumental in advancing research and development in the pharmaceutical sector. His innovative approach to treating complex diseases has garnered attention and respect within the scientific community.
Collaborations
Jaeger has collaborated with esteemed colleagues, including Heinz Rupp and Bernd Eisele. These partnerships have contributed to the successful development of his patented methods and have enhanced the overall impact of his work in the field.
Conclusion
Bodo Jaeger's contributions to pharmaceutical innovations demonstrate his commitment to addressing significant health challenges. His patent reflects a deep understanding of complex biological processes and offers promising avenues for future research and treatment options.